rilpivirine

FDA slams GSK's monthly HIV injectable with CRL, citing manufacturing issues
Endpoints
Mon, 12/23/19 - 11:44 pm
FDA
complete response letter
GSK
HIV
cabotegravir
rilpivirine
J&J's HIV Drug Edurant and Other Similar Drugs May Be Effective in Treating Zika Viruses
BioSpace
Fri, 11/1/19 - 07:02 pm
JNJ
Zika virus
rilpivirine
GSK's ViiV reports positive data for long-acting two-drug HIV therapy
Biopharma Dive
Thu, 08/22/19 - 11:46 am
ViiV Healthcare
GSK
HIV
cabotegravir
rilpivirine
ViiV Healthcare begins study on implementation of once-monthly injectable HIV treatment
Pharmaceutical Business Review
Tue, 07/9/19 - 08:51 am
ViiV Healthcare
HIV
cabotegravir
rilpivirine
ViiV Submits NDA for Once-Per-Month HIV Injectable
BioSpace
Mon, 04/29/19 - 08:54 pm
ViiV Healthcare
FDA
HIV
HIV-1
cabotegravir
rilpivirine
ViiV Healthcare announces Juluca (dolutegravir/rilpivirine) maintains HIV viral suppression at 148-weeks
Pharmaceutical Business Review
Thu, 04/4/19 - 11:58 am
ViiV Healthcare
Dolutegravir
rilpivirine
JNJ
Janssen
HIV
Long-lasting HIV injection is a step closer after second GSK study
Reuters
Wed, 10/31/18 - 09:53 am
vaccines
GSK
HIV
cabotegravir
rilpivirine
Should Gilead Be Worried About This New Monthly HIV Medication?
Motley Fool
Thu, 08/16/18 - 10:09 am
Gilead Sciences
HIV
JNJ
ViiV
cabotegravir
rilpivirine
Edurant
Long-acting injection boosts hopes for GSK's HIV business
Yahoo/Reuters
Wed, 08/15/18 - 09:40 am
GSK
HIV
AIDS
cabotegravir
rilpivirine
ViiV
Johnson & Johnson HIV combination succeeds in mid-stage study
Yahoo/Reuters
Tue, 11/3/15 - 09:20 am
JNJ
HIV
cabotegravir
rilpivirine
ViiV Healthcare
Gilead and Janssen expand partnership in HIV
Seeking Alpha
Mon, 12/29/14 - 10:55 am
Gilead Sciences
Janssen
HIV
tenofovir
rilpivirine
emtricitabine
Tibotec unveils results of experimental HIV drug
Fierce Biotech
Fri, 07/23/10 - 06:41 am
Tibotec
HIV
JNJ
rilpivirine